San Francisco, CA, United States of America

Gordon Bray

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gordon Bray

Introduction

Gordon Bray is a notable inventor based in San Francisco, CA. He has made significant contributions to the fields of molecular biology and growth factor regulation. With a total of 4 patents, his work focuses on developing therapies for the treatment of various pathological conditions, including cancer.

Latest Patents

Among his latest patents, Gordon Bray has developed innovative combination therapies. These inventions relate to the fields of molecular biology and growth factor regulation. More specifically, they address therapies aimed at treating pathological conditions such as cancer. His work in this area demonstrates a commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Gordon Bray has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Genentech, Inc. and Signal Pharmaceuticals, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development efforts.

Collaborations

Gordon Bray has collaborated with several talented individuals in his field. Some of his notable coworkers include Iris Chan and John Frederick Boylan. These collaborations have likely enriched his work and fostered innovation in his projects.

Conclusion

Gordon Bray's contributions to molecular biology and cancer treatment through his patents highlight his role as an influential inventor. His dedication to developing effective therapies showcases the importance of innovation in addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…